Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya (Q46421581)

22 December 2017

title

Antifungal drug susceptibility of Cryptococcus neoformans from clinical sources in Nairobi, Kenya (English)

1 reference

22 December 2017

main subject

Kenya

0 references

Cryptococcus neoformans

1 reference

Koichi Makimura

2

0 references

author name string

Christine C Bii

1

1 reference

22 December 2017

Shigeru Abe

3

1 reference

22 December 2017

Haruhiko Taguchi

4

1 reference

22 December 2017

Olga M Mugasia

5

1 reference

22 December 2017

Gutura Revathi

6

1 reference

22 December 2017

Njeri C Wamae

7

1 reference

22 December 2017

Shigeru Kamiya

8

1 reference

22 December 2017

publication date

1 January 2007

1 reference

22 December 2017

published in

Mycoses

1 reference

22 December 2017

volume

50

1 reference

22 December 2017

issue

1

1 reference

22 December 2017

page(s)

25-30

1 reference

22 December 2017

Serologic evidence for Cryptococcus neoformans infection in early childhood

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

AIDS-associated cryptococcal meningitis in Rwanda (1983-1992): epidemiologic and diagnostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Sexual cycle of Cryptococcus neoformans var. grubii and virulence of congenic a and alpha isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Global trends in the antifungal susceptibility of Cryptococcus neoformans (1990 to 2004).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Increased fluconazole resistance of Cryptococcus neoformans isolated from a patient with AIDS and recurrent meningitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Comparative evaluation of standard dilution method and commercial kit for frozen plate antifungal susceptibility testing of yeasts using 200 clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Multicenter evaluation of commercial frozen plates for microdilution broth antifungal susceptibility testing of yeasts and comparison of MIC limits recommended in NCCLS M27-A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Evidence of sexual recombination among Cryptococcus neoformans serotype A isolates in sub-Saharan Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Identification of the MATa mating-type locus of Cryptococcus neoformans reveals a serotype A MATa strain thought to have been extinct

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Cryptococcus neoformans STE12alpha regulates virulence but is not essential for mating

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Antifungal susceptibilities of Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Rates of antifungal resistance among Spanish clinical isolates of Cryptococcus neoformans var. neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Fluconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

Correlation of fluconazole MICs with clinical outcome in cryptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01293.X

10.1111/J.1439-0507.2006.01293.X

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

PubMed ID

17302744

1 reference

22 December 2017